Revolution Medicines, Inc.RVMDNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank88
3Y CAGR+77.4%
5Y CAGR+88.1%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+77.4%/yr
Annual compound
5Y CAGR
+88.1%/yr
Recent deceleration
Percentile
P88
Within normal range
vs 5Y Ago
23.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$51.07M-42.4%
2024$88.68M+87.5%
2023$47.29M+416.6%
2022$9.15M+898.3%
2021$917000.00-57.7%
2020$2.17M+4.0%
2019$2.08M+242.7%
2018$-1.46M-73100.0%
2017$2000.00-